These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 23229148)

  • 1. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
    Song QL; Li P; Li YM
    Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A squeeze-type osmotic tablet for controlled delivery of nifedipine.
    Park JS; Shin JH; Lee DH; Kim MS; Rhee JM; Lee HB; Khang G
    J Biomater Sci Polym Ed; 2008; 19(1):31-45. PubMed ID: 18177552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled porosity osmotic pump system for the delivery of diclofenac sodium: in-vitro and in-vivo evaluation.
    Emara LH; Taha NF; El-Ashmawy AA; Raslan HM; Mursi NM
    Pharm Dev Technol; 2014 Sep; 19(6):681-91. PubMed ID: 24320694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.
    Liu L; Xu X
    Int J Pharm; 2008 Mar; 352(1-2):225-30. PubMed ID: 18068918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasticizer effect and comparative evaluation of cellulose acetate and ethylcellulose-HPMC combination coatings as semipermeable membranes for oral osmotic pumps of naproxen sodium.
    Ramakrishna N; Mishra B
    Drug Dev Ind Pharm; 2002 Apr; 28(4):403-12. PubMed ID: 12056533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
    Khan ZA; Tripathi R; Mishra B
    AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of osmotic pump tablets of naproxen sodium.
    Ramakrishna N; Mishra B
    Pharmazie; 2001 Dec; 56(12):958-62. PubMed ID: 11802660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of diclofenac sodium sustained release matrix pellets: impact of polyethylene glycols molecular weight.
    Ibrahim A; Shazly A
    Acta Pol Pharm; 2014; 71(5):821-31. PubMed ID: 25362811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
    Cheng X; Sun M; Gao Y; Cao F; Zhai G
    Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium.
    Rani M; Surana R; Sankar C; Mishra B
    Acta Pharm; 2003 Dec; 53(4):263-73. PubMed ID: 14769233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hot melt granulation: a facile approach for monolithic osmotic release tablets.
    Panda RR; Tiwary AK
    Drug Dev Ind Pharm; 2012 Apr; 38(4):447-61. PubMed ID: 21954892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sandwiched osmotic tablet core for nifedipine controlled delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
    Avachat A; Kotwal V
    AAPS PharmSciTech; 2007 Oct; 8(4):E88. PubMed ID: 18181548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM; Alzoubi NM
    Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.